A preliminary human pilot epidemiology study indicated that germline single nucleotide polymorphisms of SIPA1 are significantly correlated to major clinical factors, such as estrogen receptor status and increased lymph node metastasis. This evidence concerns the gene SIPA1 and metastatic malignant neoplasm in the lymph nodes.